Placebo effects in clinical trials

被引:0
|
作者
Weihrauch, TR [1 ]
机构
[1] Bayer AG, Pharma Forschungszentrum, D-42096 Wuppertal, Germany
关键词
placebo; efficacy; side effects; clinical trials; evidence-based medicine;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It is well known that placebos evoke a variety of effects in the human body. It is less known that placebo medication can produce adverse drug reactions (ADRs). Method: The efficacy and, as the main topic, the tolerability were investigated from an international clinical data pool on placebo-controlled randomized multicenter studies of 5 different groups of indications. The therapeutic areas analyzed were neuropsychiatry (nimodipine, ipsapirone), cardiology (nisoldipine), metabolism (acarbose) and gastroenterology (hydrotalcit). Results: The placebo efficacy was evident and varied not only in comparison to 5 indication groups analyzed, but also within them. Placebo showed for example hardly an effect on the symptomatology of stroke patients with a severe neurological deficit in comparison to verum while there was a 50% improvement in symptoms following placebo application in patients with a mild stroke. In angina patients exercise tolerance increased under placebo by 10% (time to onset of ST segment depression and symptoms of angina) while verum showed a 22% improvement. In diabetes placebo had no effect as compared to baseline and to a verum on blood glucose and HbA(1C). ADRs could be observed under placebo treatment. The frequency and kind of placebo-induced ADRs varied also between the indication groups, i. e. typical CV side-effects were observed in CV controls. The placebo ADR profile was similar to the reference drug also. Some ADRs were reported even more frequently under placebo than under verum like "dry mouth" in patients with general anxiety status. Conclusions: Placebo therapy is frequently effective and is not a "non-therapy". Placebo effects can be shown only by direct comparison with a "non-therapy". A placebo therapy is frequently accompanied by adverse drug reactions (ADRs) just as a verum therapy. Placebo ADRs are frequently illness-and verum-specific. Effects and ADRs of placebo therapy must be known, to judge the effect of verum medication in controlled clinical trials. The mechanisms of placebo effects are manifold (e. g. endorphine release, conditioned learning). Since placebo therapy outside of evidence-based medicine (use of drugs without proven efficacy = pseudoplacebos) may potentially also cause serious side effects, the use may not only be useless but also harmful.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 50 条
  • [41] Neural mechanisms of expectancy-based placebo effects in antidepressant clinical trials
    Zilcha-Mano, Sigal
    Wang, Zhishun
    Peterson, Bradley S.
    Wall, Melanie M.
    Chen, Ying
    Wager, Tor D.
    Brown, Patrick J.
    Roose, Steven P.
    Rutherford, Bret R.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 116 : 19 - 25
  • [42] Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials
    Meissner, Karin
    Distel, Hans
    Mitzdorf, Ulla
    [J]. BMC MEDICINE, 2007, 5 (1)
  • [43] Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects
    Benedetti, Fabrizio
    Carlino, Elisa
    Piedimonte, Alessandro
    [J]. LANCET NEUROLOGY, 2016, 15 (07): : 736 - 747
  • [44] Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?
    Feys F.
    Bekkering G.E.
    Singh K.
    Devroey D.
    [J]. Systematic Reviews, 3 (1)
  • [45] PLACEBO/NOCEBO RESPONSES IN CLINICAL TRIALS AND PRACTICE
    Warner, J. O.
    [J]. CURRENT ALLERGY & CLINICAL IMMUNOLOGY, 2023, 36 (04) : 242 - 246
  • [46] PLACEBO IN CLINICAL DRUG TRIALS - A MULTIDISCIPLINARY REVIEW
    HAEGERSTAM, G
    HUITFELDT, B
    NILSSON, BS
    SJOVALL, J
    SYVALAHTI, E
    WAHLEN, A
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1982, 4 (04): : 261 - 278
  • [47] Use of placebo in clinical trials of mood disorders
    Lewis, L
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (08): : 883 - 883
  • [48] The persistence of the placebo response in antidepressant clinical trials
    Khan, Arif
    Redding, Nick
    Brown, Walter A.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (10) : 791 - 796
  • [49] Placebo in clinical trials for depression - Complexity and necessity
    Kupfer, DJ
    Frank, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (14): : 1853 - 1854
  • [50] Placebo response in clinical trials with schizophrenia patients
    Kinon, Bruce J.
    Potts, Alison J.
    Watson, Susan B.
    [J]. CURRENT OPINION IN PSYCHIATRY, 2011, 24 (02) : 107 - 113